Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGU

PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study

Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias Benz, Ida Sonni, Irene Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang Fendler, Michael Hofman, Thomas Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 3040;
Masatoshi Hotta
1University of California Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Gafita
2UCLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vishnu Murthy
3David Geffen School of Medicine at UCLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Benz
4University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ida Sonni
4University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Burger
5University Hospital Zurich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
6Technical University Munich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Emmett
7Department of Theranostics and Nuclear Medicine, St Vincent’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Farolfi
8IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Fendler
9University Hospital Essen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hofman
10Peter MacCallum Cancer Centre and University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Hope
11University of California San Francisco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Kratochwil
12University Hospital Heidelberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
13Ahmanson Translational Theranostics Division, Pharmacology, University of California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
4University of California, Los Angeles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias Benz, Ida Sonni, Irene Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang Fendler, Michael Hofman, Thomas Hope, Clemens Kratochwil, Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3040;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PSMA PET tumor-to-Salivary Glands ratio (PSG score) to predict response to Lu-177 PSMA radioligand therapy: an international multicenter retrospective study
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias Benz, Ida Sonni, Irene Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang Fendler, Michael Hofman, Thomas Hope, Clemens Kratochwil, Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 3040;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Can primary PET/CT staging using [68Ga]Ga-RM2 and [18F]Choline predict recurrence in prostate cancer?
  • Initial outcome of phase I study of Lu-177 Ludotadipep treatment in metastatic castration-resistant prostate cancer patients
  • [68Ga]-PSMA-11 can clarify equivocal lesions on conventional imaging and change management decisions among men with previously treated prostate cancer
Show more GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire